IO Biotech is looking for energetic and passionate research assistants with expertise in in vivo and/or in vitro research for temporary six-month positions to start immediately, with the possibility of extension. You will join our dynamic, multidisciplinary preclinical team in Copenhagen, Denmark.
The team focuses on novel modalities and delivery strategies, in vivo and ex vivo mechanism of action studies, and validation of new cancer targets using the T-win® platform. You will be part of the preclinical team and collaborate closely with the nine team members and report to Associate principal scientist / Senior scientist from the team.
The key responsibilities will be to:
- Conduct hands-on experimental work, including both in vivo and in vitro studies
- Accurately document and present research data
- Contribute to operational activities
To Succeed in This Role, You Should Have
- A minimum of Felasa B certification (or equivalent), hands-on experience with in vivo models, and the ability to perform in vivo experiments with minimal supervision, including animal handling, injections, and tissue collection, and/or experience handling primary cells, maintaining in vitro cultures, and performing functional cell assays
- Excellent communication and interpersonal skills
- Ability to work flexibly across multiple tasks
- Proficiency in Microsoft Office
- Fluency in English at all levels
Preferred Qualifications
- Experience in immunology or cancer immunology research
- Hands-on experience with murine in vivo tumor models
- Competency in flow cytometry
- Experience with immuno-assays such as ELISpot and ELISA
- Working experience with basic molecular biology techniques such as qPCR and RNAseq
- Familiarity with GxP regulations or experience working under GLP
- Previous experience in a non-academic research setting
Required Qualifications
- MSc degree in biomedicine, biology, or immunology
- For roles involving in vivo work: a minimum of Felasa B certification (EU Function AD), or equivalent valid in Denmark
- Valid work permit in Denmark
What We Offer
- The opportunity to join a lean organization where contributions have an immediate impact and are acknowledged
- An informal working culture with room to bring ideas and initiatives to life
- A competitive salary and benefits package
Application
Does this sound like the right opportunity for you? If so, we look forward to hearing from you.
Interviews will be conducted on an ongoing basis, so please upload your CV and a few lines on your motivation for the position as soon as possible.
If you have any questions about the position, feel free to contact Marion Chapellier, Assistant Principal Scientist.
More About IO Biotech
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines with the most clinically advanced therapeutic cancer vaccine program in development for patients with advanced melanoma, with a potential first-in-class FDA approval in 2026. The Company’s T-win® vaccine platform is designed to kill both tumor cells and immune-suppressive cells in the tumor microenvironment (TME). IO Biotech’s most advanced program for its lead candidate, IO102-IO103, is currently in Phase 3 development.
